Abiomed
American medical device company specializing in heart pumps
Abiomed is an American medical device company that specializes in the development and manufacture of heart pumps. The company is known for its Impella heart pump technology, which is used to support patients with severe heart conditions. Abiomed is headquartered in Danvers, Massachusetts.
History[edit]
Abiomed was founded in 1981 by Dr. David M. Lederman. The company initially focused on developing artificial hearts and circulatory support devices. Over the years, Abiomed has evolved to become a leader in the field of percutaneous heart pumps.
Products[edit]
Abiomed's primary product line is the Impella series of heart pumps. These devices are designed to provide temporary support to the heart, allowing it to rest and recover. The Impella pumps are inserted percutaneously and can be used in various clinical settings, including during high-risk percutaneous coronary intervention (PCI) and in cases of cardiogenic shock.
Impella Heart Pumps[edit]
The Impella heart pumps are small, catheter-based devices that are inserted through the femoral artery and positioned in the left ventricle. They work by drawing blood from the left ventricle and expelling it into the ascending aorta, thereby reducing the workload on the heart and improving cardiac output.
Research and Development[edit]
Abiomed invests heavily in research and development to advance its heart pump technology. The company collaborates with leading medical institutions and participates in clinical trials to expand the indications for its devices and improve patient outcomes.
Corporate Structure[edit]
Abiomed is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol ABMD. The company has a global presence, with offices and facilities in several countries.
Impact on Cardiology[edit]
Abiomed's heart pump technology has had a significant impact on the field of cardiology. The Impella devices have been shown to improve survival rates in patients with severe heart conditions and have become an essential tool in the management of acute heart failure.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
